Pentosidine in serum and synovial fluid in patients with knee osteoarthritis and its potential role of prediction of osteoarthritis progression

Ítems similars

• Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein
  per: Senolt, L, et al.
  Publicat: (2005)
• OPG and RANKL in serum and synovial fluids of patients with rheumatoid arthritis, osteoarthritis and spondylarthropathy
  per: Krystufkova, O, et al.
  Publicat: (2003)
• Serum and bone pentosidine in patients with low impact hip fractures and in patients with advanced osteoarthritis
  per: Vaculík, Jan, et al.
  Publicat: (2016)
• Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum
  per: Šenolt, L, et al.
  Publicat: (2007)
• The Potential of Multiple Synovial-Fluid Protein-Concentration Analyses in the Assessment of Knee Osteoarthritis
  per: Driban, Jeffrey B., et al.
  Publicat: (2010)